Valneva SE announced the appointment of two leading vaccine experts to its Scientific Advisory Board (SAB). Dr. Stanley A. Plotkin, MD and Dr. Anna Durbin, MD, have joined Valneva’s SAB. Dr. Stanley Plotkin serves as a consultant to the vaccine industry and is an emeritus professor at both the Wistar Institute and University of Pennsylvania. He developed the rubella vaccine, which is now used worldwide, and has played a pivotal role in both the development and application of various other vaccines including polio, rabies, varicella, rotavirus and cytomegalovirus. He is the author of more than 800 research papers and has edited several books including the textbook Vaccines. Dr. Plotkin has served as the senior assistant surgeon with the Epidemic Intelligence Service, U.S.Public Health Service, director of the division of infectious diseases at Children’s Hospital of Philadelphia, associate Chairman of the department of pediatrics at the University of Pennsylvania and Medical Director at Sanofi Pasteur for seven years. Dr. Anna Durbin is a professor of international health at Johns Hopkins University’s Bloomberg School of Public Health with a joint appointment in the School of Medicine. She is trained in Internal Medicine and Infectious Diseases. Dr. Durbin joined the Center for Immunization Research in 1999 as a Principal Investigator conducting clinical trials for live attenuated flavivirus vaccines. She has expertise in the evaluation of a variety of vaccines, including dengue, West Nile and malaria. Dr. Durbin has served on national and international advisory boards and committees related to dengue and malaria vaccine safety, as well as the JHSPH Institutional Review Board. Dr. Durbin received the NIH Merit Award for outstanding basic and translational research in developing vaccines for the prevention of respiratory virus and flavivirus diseases, the NIH Director’s Award and the Vaccine Industry Excellence Award for Best Academic Research Team.